IL10 and Alzheimer disease: In contrast, the anti-inflammatory factor IL-10 was not significantly changed in the group treated with feline AD-MSC-derived exosomes (230.01 ± 25.14 pg/mL) compared with the groups treated with LPS alone (183.40 ± 66.28 pg/mL) and with LPS together with feline fibroblast-derived exosomes (159.55 ± 36.83 pg/mL).